Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab

OBJECTIVE: To determine the prevalence of recurrent wheezing (RW) in preterm infants who received prophylaxis against severe infection with respiratory syncytial virus (RSV) and to identify genetic susceptibility (atopy or asthma) and risk factors for RW. METHODS: This was a cross-sectional study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Manini, Mariana Bueno, Matsunaga, Natasha Yumi, Gianfrancesco, Lívea, Oliveira, Marina Simões, de Carvalho, Maria Rosa Vieira, Ribeiro, Gisleine Leila Martins Tengler, Morais, Eliane de Oliveira, Ribeiro, Maria Angela Gonçalves O., Morcillo, André Moreno, Ribeiro, José Dirceu, Toro, Adyléia Aparecida Dalbo Contrera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013528/
https://www.ncbi.nlm.nih.gov/pubmed/34669834
http://dx.doi.org/10.36416/1806-3756/e20210157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013528/
https://www.ncbi.nlm.nih.gov/pubmed/34669834
http://dx.doi.org/10.36416/1806-3756/e20210157

Ejemplares similares